accessibility menu, dialog, popup

UserName
Viewing profile as user:

Sugar acids and derivatives

Monosacharides with a carboxyl group at one or both ends of their chain; includes aldonic, ulosonic, uronic, and aldaric acids; may act as sequestering agents and binders, corrosion inhibitors, biodegradable chelators for pharmaceuticals, or pH regulators.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (4)
  • (1)
  • (3)

special interests

  • (9)

Search Within Results
Keyword Search:
1 – 9 of 9 results
1

Medchemexpress LLC Hydroxypyruvic acid | 1113-60-6 | 104.06 | 1 MG
SDP

Hydroxypyruvic acid is an intermediate in the metabolism of glycine, serine, and threonine. It serves as a substrate for serine-pyruvate aminotransferase and glyoxylate reductase/hydroxypyruvate reductase. This compound is involved in the metabolic disorder of dimethylglycine dehydrogenase deficiency pathway.

  • Targeted as an endogenous metabolite
  • Used in metabolic disease research
  • Applicable in human gut microbiota metabolites research
  • Classified under ketones, aldehydes, and acids
  • Useful in disease research fields
  • Source classification research applications

ENCOMPASS_PREFERRED
2

Alkali Scientific Leupeptin Hemisulfate, 1 Milligram
SDP

Leupeptin Hemisulfate is a potent protease inhibitor available in a 1-milligram quantity. It is primarily used in biochemical research to inhibit serine, cysteine, and threonine proteases. Leupeptin is commonly employed to prevent proteolysis in experiments involving protein isolation, enzyme assays, and cell culture studies. By inhibiting a wide range of proteases, Leupeptin preserves the integrity of proteins during their extraction and purification processes. This reagent is essential for studies focusing on enzyme activity, protein-protein interactions, and various cellular mechanisms in both in vitro and in vivo research applications.

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Beta-casein phosphopeptide | 183582-09-4 | 99.19% | 2061.96 | 10 MG
SDP

beta-Casein phosphopeptide is a biologically active peptide derived from bovine beta-Casein. This monophosphopeptide (phospho-Serine) is primarily used for the characterization of affinity-purified phosphorylated peptides in liquid chromatography and for the analysis or detection of phosphorylated peptides in mass spectrometry. This product is for research use only.

  • Biologically active peptide
  • Used for characterization of phosphorylated peptides
  • Suitable for liquid chromatography and mass spectrometry applications
  • For research use only

ENCOMPASS_PREFERRED
4

Medchemexpress LLC Heparin Lithium salt | 9045-22-1 | MFCD00131308 | 1 G
SDP

Heparin Lithium salt is an anticoagulant that reversibly binds to antithrombin III (ATIII). It significantly inhibits exosome-cell interactions. Heparin is a potent anticoagulant drug, accelerating the rate at which antithrombin inhibits serine proteases in the blood coagulation cascade.

  • Anticoagulant
  • Reversibly binds to antithrombin III (ATIII)
  • Inhibits exosome-cell interactions
  • Enhances AT-III-mediated inhibition of blood coagulation factors
  • Promotes FGFR dimerization
  • For research use only

ENCOMPASS_PREFERRED
5

Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 1mg
SDP

Heparin cofactor II precursor fragment is a thrombin inhibitor peptide targeting human thrombin (factor IIa) It is designed to inhibit thrombin activity thereby modulating blood coagulation pathways Heparin cofactor II precursor fragment exerts its biological activity primarily through serine protease inhibition facilitated in the presence of heparin or dermatan sulfate Based on these pharmacological properties heparin cofactor II precursor fragment holds research potential in investigating thrombin inhibition mechanisms blood coagulation pathways and conditions associated with altered coagulation such as heparin cofactor II deficiency and hypercoagulability disorders

ENCOMPASS_PREFERRED
6

Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 5mg
SDP

Heparin cofactor II precursor fragment is a thrombin inhibitor peptide targeting human thrombin (factor IIa) It is designed to inhibit thrombin activity thereby modulating blood coagulation pathways Heparin cofactor II precursor fragment exerts its biological activity primarily through serine protease inhibition facilitated in the presence of heparin or dermatan sulfate Based on these pharmacological properties heparin cofactor II precursor fragment holds research potential in investigating thrombin inhibition mechanisms blood coagulation pathways and conditions associated with altered coagulation such as heparin cofactor II deficiency and hypercoagulability disorders

ENCOMPASS_PREFERRED
7

Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 25mg
SDP

Heparin cofactor II precursor fragment is a thrombin inhibitor peptide targeting human thrombin (factor IIa) It is designed to inhibit thrombin activity thereby modulating blood coagulation pathways Heparin cofactor II precursor fragment exerts its biological activity primarily through serine protease inhibition facilitated in the presence of heparin or dermatan sulfate Based on these pharmacological properties heparin cofactor II precursor fragment holds research potential in investigating thrombin inhibition mechanisms blood coagulation pathways and conditions associated with altered coagulation such as heparin cofactor II deficiency and hypercoagulability disorders

ENCOMPASS_PREFERRED
8

Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 10mg
SDP

Heparin cofactor II precursor fragment is a thrombin inhibitor peptide targeting human thrombin (factor IIa) It is designed to inhibit thrombin activity thereby modulating blood coagulation pathways Heparin cofactor II precursor fragment exerts its biological activity primarily through serine protease inhibition facilitated in the presence of heparin or dermatan sulfate Based on these pharmacological properties heparin cofactor II precursor fragment holds research potential in investigating thrombin inhibition mechanisms blood coagulation pathways and conditions associated with altered coagulation such as heparin cofactor II deficiency and hypercoagulability disorders

ENCOMPASS_PREFERRED
9

Cayman Chemical Androsterone 1g
SDP

A covalent inhibitor of PME-1 (IC50 4.2 nM) selectively inhibits PME-1 over 50 other serine hydrolases in MDA-MB-231 and HEK293T cell lysates at 10 M decreases proliferation of Ishikawa cells and migration of ECC-1 endometrial carcinoma cells when used at a concentration of 50 nM

ENCOMPASS_PREFERRED